Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qingying oral liquid is a Traditional Chinese Medicine (TCM) formulation based on the classical Qingying Tang (Clear the Nutritive Level Decoction), first recorded in the 'Wenbing Tiaobian' (Systematic Differentiation of Warm Diseases). It is primarily indicated for syndromes where pathogenic heat has penetrated the 'Ying' (nutritive) level of the body, a state often associated with severe febrile illnesses and systemic inflammatory responses. The formulation consists of a complex mixture of botanical and animal-derived ingredients, including Water Buffalo Horn (Bubali Cornu), Rehmannia root, and Coptis rhizome. Pharmacologically, it exerts antipyretic, anti-inflammatory, and anti-endotoxin effects by suppressing the production of pro-inflammatory cytokines and modulating the immune response. It is widely used in China for the treatment of high fever, irritability, thirst, and skin eruptions associated with infectious diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Qingying oral liquid.